Synchrony Labs

Synchrony Labs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

Synchrony Labs is a specialized preclinical contract research organization (CRO) with a 40+ year legacy originating from cardiology leaders at Duke University. The company operates state-of-the-art laboratories in North Carolina's Research Triangle, offering end-to-end services including study design, protocol development, device implantation, and regulatory reporting for medical device and biopharma clients. Its core value proposition is providing flexible, deadline-driven, and GLP-compliant testing with a team of seasoned veterinarians, physicians, and data scientists to de-risk and advance novel medical technologies. While positioned in the Digital Health/AI sector, its current operations are firmly centered on expert preclinical services rather than developing its own therapeutic or diagnostic products.

Cardiovascular

Technology Platform

Integrated preclinical service platform featuring GLP-compliant laboratories, specialized surgical suites for large animal models, and a team of expert veterinarians and physicians. Expertise is the core platform, not a licensable technology.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The growing and innovative medical device sector creates consistent demand for high-quality preclinical data.
The company can leverage its 'Digital Health/AI' sector tag to develop integrated data science and predictive analytics services, offering a next-generation CRO model.
Geographic location in the Research Triangle provides access to a dense network of potential clients.

Risk Factors

Faces intense competition from both large global CROs and niche specialists.
Revenue is dependent on the R&D spending cycles of biotech and medtech clients, which can be volatile.
Operational reputation hinges entirely on maintaining flawless GLP compliance and data integrity, where any failure could be catastrophic.

Competitive Landscape

Competes in the preclinical CRO market against large, diversified players (e.g., Charles River, Labcorp) and smaller specialty labs. Its differentiation is based on deep, hands-on expertise in complex surgical models (especially cardiovascular), a team blending DVMs and MDs, and a focus on flexible, client-collaborative service rather than high-volume throughput.